{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:13:59Z","timestamp":1791180839188,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T00:00:00Z","timestamp":1281657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s10143-010-0280-7","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T02:31:44Z","timestamp":1281580304000},"page":"441-449","source":"Crossref","is-referenced-by-count":107,"title":["First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience"],"prefix":"10.1007","volume":"33","author":[{"given":"Hans Christoph","family":"Bock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian Josef Anton","family":"Puchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sch\u00fctze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Koll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Ketter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruediger","family":"Buchalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Rainov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven R.","family":"Kantelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alf","family":"Giese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,13]]},"reference":[{"key":"280_CR1","unstructured":"Asher A (2007) Prospective analysis of temozolomide as adjuvant to Gliadel and radiation in newly diagnosed malignant glioma. Abstract presented at the Annual Meeting of the American Association of Neurological Surgeons, Washington, DC 2007"},{"key":"280_CR2","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","volume":"345","author":"H Brem","year":"1995","unstructured":"Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345:1008\u20131012","journal-title":"Lancet"},{"key":"280_CR3","unstructured":"Cancer Therapy Evaluation Program (2006) Common terminology criteria for adverse events, version 3.0, DCTD, NCI, NIH, DHHS, March 31, 2003 ( http:\/\/ctep.cancer.gov ). Publish Date: August 9"},{"key":"280_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3171\/JNS\/2008\/108\/2\/0236","volume":"108","author":"BJ Darakchiev","year":"2008","unstructured":"Darakchiev BJ, Albright RE, Breneman JC, Warnick RE (2008) Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme. J Neurosurg 108:236\u2013242","journal-title":"J Neurosurg"},{"key":"280_CR5","first-page":"672","volume":"58","author":"LK Fung","year":"1998","unstructured":"Fung LK, Ewend MG, Sills A, Sipos EP, Thompson R, Watts M, Colvin OM, Brem H, Saltzman WM (1998) Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res 58:672\u2013684","journal-title":"Cancer Res"},{"key":"280_CR6","doi-asserted-by":"publisher","unstructured":"Giese A, Bock HC, Kantelhardt SR, Rohde V (2010): Risk Management in the Treatment of Malignant Gliomas with BCNU Wafer Implants. Jan 8. doi: 10.1055\/s-0029-1242775","DOI":"10.1055\/s-0029-1242775"},{"key":"280_CR7","first-page":"246","volume":"3","author":"S Gururangan","year":"2001","unstructured":"Gururangan S, Cokgor L, Rich JN, Edwards S, Affronti ML, Quinn JA, Herndon JE 2nd, Provenzale JM, McLendon RE, Tourt-Uhlig S, Sampson JH, Stafford-Fox V, Zaknoen S, Early M, Friedman AH, Friedman HS (2001) Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro Oncol 3:246\u2013250","journal-title":"Neuro Oncol"},{"key":"280_CR8","doi-asserted-by":"crossref","unstructured":"Heery CR, Desjardins A, Quinn JA, Rich JN, Gururangan S, Vredenburgh JJ et al (2006) Acute toxicity analysis of patients receiving surgery, Gliadel wafer implantation, and postoperative daily temozolomide with radiation therapy for primary high-grade glioma. Journal Clinical Oncology, ASCO Annual Meeting Proceedings (Post-Meeting Edition), vol 24(18S), p 11504","DOI":"10.1200\/jco.2006.24.18_suppl.11504"},{"issue":"3","key":"280_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/01.wnq.0000174599.99440.68","volume":"15","author":"R LaRocca","year":"2006","unstructured":"LaRocca R, Glisson S, Hargis J, Petruska D, Villanueva W, Morassutti D et al (2006) High-grade glioma treated with surgery; carmustine wafer; postoperative radiation; and procarbazine, lomustine, and vincristine chemotherapy. Neurosurg Q 15(3):167\u2013171","journal-title":"Neurosurg Q"},{"key":"280_CR10","doi-asserted-by":"crossref","unstructured":"LaRocca RV, Hodes J, Villanueva WG, Vitaz TW, Morassutti DJ, Doyle MJ, et al (2006) A phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients with newly diagnosed supratentorial high-grade malignant glioma who have undergone surgery with carmustine (BCNU) wafer insertion: Abstract presented at the Annual Meeting of the Society of Neuro-oncology, Orlando, FL (Abstract)","DOI":"10.1200\/jco.2005.23.16_suppl.1547"},{"key":"280_CR11","doi-asserted-by":"crossref","unstructured":"Lawson DH, Phuphanich S, McKenzie E, Greiner K, Shires K, Olson J (2006) Phase I analysis of systemic interferon alpha utilized with gliadel in adults with recurrent glioblastoma multiforme (GBM). Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I, Vol 24, No 18S (June 20 Supplement), p 11508","DOI":"10.1200\/jco.2006.24.18_suppl.11508"},{"key":"280_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11060-004-2339-1","volume":"72","author":"SA Limentani","year":"2005","unstructured":"Limentani SA, Asher A, Heafner M, Kim JW, Fraser R (2005) A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme. J Neurooncol 72:241\u2013244","journal-title":"J Neurooncol"},{"issue":"3","key":"280_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3171\/2008.5.17557","volume":"110","author":"MJ McGirt","year":"2009","unstructured":"McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello FJ, Olivi A, Laterra J, Kleinberg LR, Grossman SA, Brem H, Qui\u00f1ones-Hinojosa A (2009) Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg 110(3):583\u2013588","journal-title":"J Neurosurg"},{"key":"280_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1086\/368082","volume":"36","author":"PC McGovern","year":"2003","unstructured":"McGovern PC, Lautenbach E, Brennan PJ, Lustig RA, Fishman NO (2003) Risk factors for postcraniotomy surgical site infection after 1, 3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement. Clin Infect Dis 36:759\u2013765","journal-title":"Clin Infect Dis"},{"key":"280_CR15","volume-title":"Gliadel\u00ae Wafer [prescribing information]","author":"MGI Pharma","year":"2006","unstructured":"MGI Pharma (2006) Gliadel\u00ae Wafer [prescribing information] MGI PHARMA, Bloomington"},{"key":"280_CR16","volume-title":"Gliadel\u00ae Wafer [summary of product characteristics]","author":"MGI Pharma","year":"2006","unstructured":"MGI Pharma (2006) Gliadel\u00ae Wafer [summary of product characteristics] MGI PHARMA, West Sussex, UK"},{"key":"280_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11060-008-9576-7","volume":"88","author":"E Pan","year":"2008","unstructured":"Pan E, Mitchell SB, Tsai JS (2008) A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients. J Neurooncol 88:353\u2013357","journal-title":"J Neurooncol"},{"key":"280_CR18","first-page":"3793","volume":"54","author":"J Plowman","year":"1994","unstructured":"Plowman J, Waud WR, Koutsoukos AD, Rubinstein LV, Moore TD, Grever MR (1994) Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1, 3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 54:3793\u20133799","journal-title":"Cancer Res"},{"issue":"11","key":"280_CR19","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1185\/03007990802508180","volume":"24","author":"M Sabel","year":"2008","unstructured":"Sabel M, Giese A (2008) Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience. Curr Med Res Opin 24(11):3239\u20133257","journal-title":"Curr Med Res Opin"},{"key":"280_CR20","unstructured":"Sampath P, Weaver CE, Alderson L, Duncan JA, Stopa E, Fountas KN (2005) Consecutive use of brachytherapy (Gliasite) and intratumoral chemotherapy (Gliadel) for recurrent glioblastoma: a phase I\/II study with independent clinical review. Poster and abstract presented at the Annual Meeting of the Congress of Neurological Surgeons, Boston, MA, (Abstract)"},{"key":"280_CR21","unstructured":"Smith KA, Ashby L, Gonzolas F (2006) Gross total resection (GTR) with Gliadel\u00ae Wafer implantation followed by post-operative gamma knife radiosurgery and adjuvant fractionated radiotherapy for newly diagnosed GBM: phase I\/II study of safety and efficacy in 30 consecutive patients. Abstract presented at the Annual Meeting of the Congress of Neurological Surgeons, Chicago, IL (Abstract)"},{"key":"280_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"280_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jbm.820230209","volume":"23","author":"RJ Tamargo","year":"1989","unstructured":"Tamargo RJ, Epstein JI, Reinhard CS, Chasin M, Brem H (1989) Brain biocompatibility of a biodegradable, controlled-release polymer in rats. J Biomed Mater Res 23:253\u2013266","journal-title":"J Biomed Mater Res"},{"key":"280_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00006123-199707000-00011","volume":"41","author":"S Valtonen","year":"1997","unstructured":"Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O, Unsgaard G, Kuurne T (1997) Interstitial chemotherapy with carmustine-loaded polymers for high grade gliomas: A randomized double-blind study. Neurosurg 41:44-49","journal-title":"Neurosurg"},{"key":"280_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/neuonc\/5.2.79","volume":"5","author":"M Westphal","year":"2003","unstructured":"Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC et al (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5:79\u201388","journal-title":"Neuro Oncol"},{"key":"280_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00701-005-0707-z","volume":"148","author":"M Westphal","year":"2006","unstructured":"Westphal M, Ram Z, Riddle V, Hilt D, Bortey E (2006) Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 148:269\u2013275, discussion 275","journal-title":"Acta Neurochir (Wien)"},{"key":"280_CR27","unstructured":"Zamorano L, Li Q, Levin K, Barger G (2005) Brachytherapy with I-125 permanent implant combined with sequential Gliadel in the treatment of patients with GBM. Abstract presented at the Annual Meeting of the Congress of Neurological Surgeons, Boston, MA (Abstract)"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-010-0280-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10143-010-0280-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-010-0280-7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-010-0280-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T05:32:58Z","timestamp":1591767178000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10143-010-0280-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,13]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["280"],"URL":"https:\/\/doi.org\/10.1007\/s10143-010-0280-7","relation":{},"ISSN":["0344-5607","1437-2320"],"issn-type":[{"value":"0344-5607","type":"print"},{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,13]]}}}